Status:
RECRUITING
Effect of Chlorhexidine Versus Alcohol on Infections in Neonates
Lead Sponsor:
Ain Shams University
Conditions:
Neonatal Infection
Eligibility:
All Genders
Up to 28 years
Phase:
NA
Brief Summary
Chlorhexidine is a local antiseptic that has an important role in the prevention of catheter-associated bloodstream infections. Its application to a newborn's umbilical cord reduces all-cause neonatal...
Detailed Description
Skin disinfection by an appropriate antiseptic agent is essential to prevent healthcare-associated infection. Common pathogens responsible for sepsis have been detected in skin microbiota of hospitali...
Eligibility Criteria
Inclusion
- Neonates with gestational age 28 weeks or more.
- Neonates needing the insertion of a peripherally inserted central catheter (PICC line) or CVC or umbilical catheter.
Exclusion
- Extremely preterm (GA less than 28 weeks).
- Babies who have an allergy to chlorhexidine 2%.
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06194396
Start Date
May 1 2023
End Date
July 1 2024
Last Update
March 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Hospital
Cairo, Egypt, 11865